BG61931B1 - Фармацевтични състави, съдържащи производни на фурана - Google Patents

Фармацевтични състави, съдържащи производни на фурана Download PDF

Info

Publication number
BG61931B1
BG61931B1 BG99021A BG9902194A BG61931B1 BG 61931 B1 BG61931 B1 BG 61931B1 BG 99021 A BG99021 A BG 99021A BG 9902194 A BG9902194 A BG 9902194A BG 61931 B1 BG61931 B1 BG 61931B1
Authority
BG
Bulgaria
Prior art keywords
composition according
methyl
bismuth
ranitidine
complex
Prior art date
Application number
BG99021A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99021A (bg
Inventor
Stephen J. Douglas
Colin R. Heppenstall
Norman R. Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BG99021A publication Critical patent/BG99021A/bg
Publication of BG61931B1 publication Critical patent/BG61931B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
BG99021A 1990-09-11 1994-09-01 Фармацевтични състави, съдържащи производни на фурана BG61931B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (2)

Publication Number Publication Date
BG99021A BG99021A (bg) 1995-06-30
BG61931B1 true BG61931B1 (bg) 1998-10-30

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99021A BG61931B1 (bg) 1990-09-11 1994-09-01 Фармацевтични състави, съдържащи производни на фурана

Country Status (33)

Country Link
US (1) US5456925A (no)
EP (1) EP0558779B1 (no)
JP (1) JPH0692849A (no)
KR (1) KR100196308B1 (no)
AT (2) AT405134B (no)
AU (2) AU640816B2 (no)
BE (1) BE1005115A5 (no)
BG (1) BG61931B1 (no)
CA (1) CA2050970C (no)
CH (1) CH683068A5 (no)
CY (1) CY1988A (no)
DE (2) DE4130061A1 (no)
DK (1) DK159191A (no)
ES (1) ES2072647T3 (no)
FI (1) FI944047A (no)
FR (1) FR2666508B1 (no)
GB (2) GB9019875D0 (no)
HK (1) HK60894A (no)
HU (1) HU211846A9 (no)
IE (1) IE65049B1 (no)
IL (1) IL99428A (no)
IT (1) IT1249696B (no)
MX (1) MX9101009A (no)
NL (1) NL194907C (no)
NO (1) NO179694C (no)
NZ (1) NZ239731A (no)
OA (1) OA10093A (no)
RO (1) RO112084B1 (no)
RU (1) RU2108097C1 (no)
SE (1) SE509694C2 (no)
SK (1) SK279591B6 (no)
WO (1) WO1993017679A1 (no)
ZA (1) ZA917176B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
AU1513699A (en) * 1998-08-18 2000-03-14 Nikolai Borisovich Leonidov Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN102099017A (zh) * 2008-07-21 2011-06-15 雅宝公司 高含量布洛芬钠颗粒、其制备及其在制备非泡腾固体剂型中的用途
CN115697354A (zh) * 2020-06-01 2023-02-03 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (no) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
BG99021A (bg) 1995-06-30
KR920005984A (ko) 1992-04-27
IT1249696B (it) 1995-03-09
CH683068A5 (fr) 1994-01-14
JPH0692849A (ja) 1994-04-05
IE913191A1 (en) 1992-04-22
GB2248185B (en) 1994-02-02
EP0558779B1 (en) 1995-05-24
CY1988A (en) 1997-09-05
DK159191D0 (da) 1991-09-10
IL99428A0 (en) 1992-08-18
ATE122883T1 (de) 1995-06-15
SK106094A3 (en) 1995-02-08
DK159191A (da) 1992-03-12
ATA180191A (de) 1998-10-15
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
MX9101009A (es) 1992-05-04
FR2666508B1 (fr) 1994-02-18
SE509694C2 (sv) 1999-02-22
OA10093A (en) 1996-12-18
NL9101533A (nl) 1992-04-01
NZ239731A (en) 1993-10-26
NO179694B (no) 1996-08-26
FR2666508A1 (fr) 1992-03-13
GB9019875D0 (en) 1990-10-24
FI944047A0 (fi) 1994-09-02
SK279591B6 (sk) 1999-01-11
RU2108097C1 (ru) 1998-04-10
RO112084B1 (ro) 1997-05-30
CA2050970A1 (en) 1992-03-12
CA2050970C (en) 2002-11-19
AU640816B2 (en) 1993-09-02
EP0558779A1 (en) 1993-09-08
ITRM910673A0 (it) 1991-09-10
IE65049B1 (en) 1995-10-04
HU211846A9 (en) 1995-12-28
US5456925A (en) 1995-10-10
NL194907C (nl) 2003-07-04
ZA917176B (en) 1992-06-24
AT405134B (de) 1999-05-25
ES2072647T3 (es) 1995-07-16
ITRM910673A1 (it) 1993-03-10
NO179694C (no) 1996-12-04
BE1005115A5 (fr) 1993-04-27
KR100196308B1 (ko) 1999-06-15
NO920408D0 (no) 1992-01-30
AU8375791A (en) 1992-03-19
DE69202696D1 (de) 1995-06-29
AU1334792A (en) 1993-10-05
SE9102604D0 (sv) 1991-09-10
IL99428A (en) 1996-06-18
HK60894A (en) 1994-07-08
FI944047A (fi) 1994-09-02
GB9119284D0 (en) 1991-10-23
NO920408L (no) 1993-08-02
GB2248185A (en) 1992-04-01
WO1993017679A1 (en) 1993-09-16
DE4130061A1 (de) 1992-03-12

Similar Documents

Publication Publication Date Title
BG61931B1 (bg) Фармацевтични състави, съдържащи производни на фурана
JPH0482832A (ja) 医薬組成物
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
BG60526B2 (bg) Фармацевтичен препарат
US5002946A (en) Phenylethanolamine analog active compounds for the treatment of gastrointestinal diseases
RU94040869A (ru) Фармацевтические композиции, содержащие соли ранитидина и карбоксилаты висмута, и способ их получения
US5728401A (en) Effervescent ranitidine formulations
JPH08512321A (ja) Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
RU2197244C2 (ru) Фармацевтическая композиция и фармацевтический препарат, содержащие калиевую, натриевую и трис соли оксапрозина, их применение для устранения или уменьшения боли у млекопитающего и для лечения воспаления и нарушений, связанных с воспалением у млекопитающего, способ получения фармацевтического препарата
JPS60163823A (ja) 経口投与製剤
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
CZ281514B6 (cs) Farmaceutický prostředek
HU217587B (hu) Ranitidint és bizmut-karboxilát-komplexet, valamint bázisos sókat tartalmazó gyógyászati készítmények
JPS63233919A (ja) 薬学的組成物
KR100593795B1 (ko) 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
RU2134579C1 (ru) Лекарственные средства для лечения воспалительных состояний или для анальгезии